Department of Orthopedic Surgery, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Republic of Korea.
Department of Orthopedic Surgery, Chungnam National University Sejong Hospital, Chungnam National University College of Medicine, Sejong, 30099, Republic of Korea.
J Orthop Surg Res. 2023 Feb 28;18(1):148. doi: 10.1186/s13018-023-03637-4.
Albeit with no disease-modifying effects, intra-articular steroid injections (IASIs) are still widely used to relieve symptoms of knee osteoarthritis. Previous literature has reported conflicting results regarding the safety of IASI in terms of periprosthetic joint infection (PJI) in total knee arthroplasty (TKA). This study tried to determine whether preoperative IASIs increased the risk of PJI, with different time intervals between the injections and surgery.
A computerized search of MEDLINE, EMBASE, and Cochrane Library was conducted for studies published before October 2022, which investigated the PJI rates of patients who received IASIs before TKA and patients who did not. The primary outcome was the association between preoperative IASI and PJI in TKA. The time point from which IASIs could be applied without risking PJI was also assessed.
Fourteen studies, with 113,032 patients in the IASI group and 256,987 patients in the control group, were included. The pooled odds ratio of PJI was 1.13 (95% confidence interval [CI] 1.00-1.27, p = 0.05), indicating no increased risk of PJI. With the time interval < 6 months, the pooled odds ratio was 1.19 (95% CI 0.99-1.43, p = 0.06). However, with the time interval < 3 months, the pooled odds ratio was 1.26 (95% CI 1.06-1.50, p < 0.01).
IASI is not a safe procedure for patients who are expected to undergo TKA. The time interval between the injections and surgery was an important factor in assessing the safety of IASI. Preoperative injections that were applied within 3 months increased the risk of PJI in TKA.
尽管关节内类固醇注射(IASIs)没有疾病修饰作用,但仍广泛用于缓解膝骨关节炎的症状。先前的文献报告了 IASI 在全膝关节置换术(TKA)中与假体周围关节感染(PJI)相关的安全性结果相互矛盾。本研究试图确定在不同的注射与手术间隔时间内,术前 IASI 是否会增加 PJI 的风险。
对 2022 年 10 月之前发表的研究进行了计算机检索,包括 MEDLINE、EMBASE 和 Cochrane 图书馆,这些研究调查了接受 TKA 前接受 IASI 和未接受 IASI 的患者的 PJI 发生率。主要结局是 TKA 中术前 IASI 与 PJI 之间的关联。还评估了可以应用 IASI 而不会有 PJI 风险的时间点。
纳入了 14 项研究,IASI 组有 113032 例患者,对照组有 256987 例患者。PJI 的汇总优势比为 1.13(95%置信区间 [CI] 1.00-1.27,p=0.05),表明 PJI 风险没有增加。当时间间隔<6 个月时,汇总优势比为 1.19(95% CI 0.99-1.43,p=0.06)。然而,当时间间隔<3 个月时,汇总优势比为 1.26(95% CI 1.06-1.50,p<0.01)。
IASI 对预计接受 TKA 的患者不是一种安全的程序。注射与手术之间的时间间隔是评估 IASI 安全性的重要因素。在 3 个月内进行的术前注射增加了 TKA 中 PJI 的风险。